I can see that your discussion is solely based on your PPS cost basis since you were in at such a low price. But we all had the same opportunity to add and thereby profit from a different point didn't we? I'm not saying it didn't set us back 6-9 months but that is the time frame we are expecting "the" good news so it shouldn't matter in the long run. But you're right - JP Morgan is a POS and I didn't like the way the deal was brokered but I played the ball where it laid.
A tiny observation - when the SP was down and they had just issued the converitbles, Erck was made to look like Madoff's twin. Not long ago the bashers (and a few longs) were ready to lynch SE and highly questioned his strategy. My, my - how things have changed.
Sentiment: Strong Buy
Looks like the merger breakup is a win/win for them. The breakup fee and being unsaddled. Of course having a strong balance sheet doesn't hurt along with the posibility of a CNC merger. I'm finally back in since the JD will probably rule in the next month. Too much upside and very little downside.
There are many short comings on the short court - parden the pun. The brick and mortar banks are slowly disappearing according to a recent Yahoo article. The institutional ownership stands at 100.1% according to Scottrade and 80% here with a 41% short interest. Also inside ownership is at 9% of the 63M float of which 23M is short. So, with nearly 2m shares traded Friday (I like to round up) which is 2 x the normal 900k volume, who is shorting? The investment managers of course are toying with the SP as well as the highly coordinated shorts but one thing is for certain - it is rare to see this type of Tute coverage. I'm just here to see the 4th quarter but it WILL be good. JMO
Beegz - are the only one left here? I quit following after Romper room attendees took over.
Since you are so kind to share faves you might want to look at one I've had the pleasure of a nice run up with - FLXN. There appears to be room to run. Who knows - the Sgen run may finally have it's legs after waiting years for the sustained uptrend. I'm not the trader Fs is (not knocking it - just afraid to chase the end run).
Ah yes, 2 red thumbs for stating the truth? Must be some Ete boarder's in on the muster. So how's this red thumber's - when damages occur, the responsible party should pay. Someone run's a red light and t-bones your car or a doctor that takes out your appendix when your gall bladder is diseased etc. And who is to say SP damage is not way more than any divvy? Bottom line - they negotiated in bad faith. The merger won't go through, but certainly someone needs to be fined for reckless driving or XYZ oil will be wanting to buy Chevron.
One thing is for certain - it does present a clean cut case of bad faith bargaining.
A minor short detail - almost all of the other buyouts I've had the pleasure of being in on had one last beat down prior to the end run up. It's probably the same for you AVNR'ians. Another example of the well orchestrated shorts.
I claim market malaise and the downgrade is doubly baked in at this point for a cake walk 10 by year end not counting divvys. I'm in
How fitting from Dirt Bag DB who just so happens to have a 30 year low on their very own SP. It's easy to see they are in the shorting business. It's a nice buy in/add opportunity so I thank them for that at least and just in time for Easter and the divvy.
I could have won the jackpot on my next ouabra45 prediction - it followed like clockwork on the next nvax down day complete with TA and tea leaves. You know, I'm a certified meteorologist - when I'm come in wet, it's going to be raining outside.
Okay, a hack will see your bullet point version of your grand short pipe dream.
1. The RSV clinical trial included a larger field to insure success so is more expensive hense the increased cash burn and quicker pIII trial end point. But the cash is nonetheless there. (500mm)
2. The huge pipeline is immaterial at this point since priorities are RSV and quad-flu. Once they hit the BP pipe dream grand slam the buyout flood gates open and there's no huge need for subsequent testing.
3. No one on this board has ever given Zika 2 shakes on the money tree
4. Again, once RSV p3 has achieved endpoints bidding wars begin for the company that's halved trial times(saving lives/money) and increased odds of market success from less than 5% to greater than 40%.
5. Now, the huge pipeline doesn't seem that far away if you've got a brain larger than the size of a peanut.
Well I can't say I don't care. I've broken one of the cardinal rules of investing here. Although I won't say what percentage of nvax I have, it is well up in double digits and I still add on 10% drops especially when below 5. And you know how ugly the scorecard looks on a down day. So, I come back to regain some sense of sanity by pickling some ML, Byte, Wily, Birdy, Horcents and you know the others. So the powder is again ready for Monday and a huge thanks to the best posters of any MB on the planet.
So, what happened to the dark star? Remember the one you were predicting a week ago? Here's a little waste of our time in case you don't remember -(Rogue: I never said that Nvax will surely get to $1 or $2. There is a possibility it will. $3 is highly likely it will happen. When comes to 50 and 200 MAs cross, that is true) Forget where but you were alluding to sub 4' s and recently.
Better yet, he's probably a die hard Cleveland fan and crying since they booted Manziel. And here's a hypothesis, I think ouabra45 is none other than the re-invented Stocksgrrl. Same annoying TA 101 sky is falling lessons on momo's.